Lirac, France

Delphine Jaga

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Cisbio Bioassays. Active years: 2018.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Delphine Jaga: Innovator in Antibody Glycosylation Detection

Introduction

Delphine Jaga is a prominent inventor based in Lirac, France. She has made significant contributions to the field of biochemistry, particularly in the detection of antibody glycosylation. Her innovative work has led to the development of a patented method that enhances the understanding of antibody interactions.

Latest Patents

Delphine Jaga holds a patent for a "Method for determining the glycosylation of an antibody." This invention relates to a method for detecting the binding of an antibody to an Fc receptor present on the surface of a cell. Additionally, it provides a method for determining the level of glycosylation of an antibody. The invention also includes a reagent kit designed for carrying out these methods. She has 1 patent to her name.

Career Highlights

Delphine Jaga is currently employed at Cisbio Bioassays, where she continues to advance her research in antibody detection methods. Her work is crucial for the development of new therapeutic strategies and diagnostic tools in the biomedical field.

Collaborations

Delphine collaborates with notable colleagues, including Hamed Mokrane and Stéphane Martinez. Their combined expertise contributes to the innovative projects at Cisbio Bioassays.

Conclusion

Delphine Jaga's contributions to the field of antibody glycosylation detection exemplify her dedication to scientific innovation. Her patented methods and ongoing research continue to impact the biochemistry landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…